Bangkok Lab And Cosmetic PCL (BKK:BLC)
Thailand · Delayed Price · Currency is THB 4.040
-0.020 (-0.49%)
At close: Jul 24, 2026
BKK:BLC Financials Overview
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,655 | 1,679 | 1,579 | 1,417 | 1,242 | 1,095 |
Revenue Growth | 0.17% | 6.31% | 11.42% | 14.11% | 13.38% | -1.03% |
Gross Profit Gross Profit Growth | 962.92 | 988.37 | 894.14 | 802.1 | 704.43 | 570.65 |
Operating Income Operating Income Growth | 196.08 | 228.83 | 230.53 | 200.23 | 172.87 | 88.94 |
Net Income Net Income Growth | 146.97 | 173.02 | 171.35 | 145.39 | 125.72 | 51.61 |
Earnings Per Share EPS Growth | 0.25 | 0.29 | 0.29 | 0.27 | 0.28 | 0.14 |
EPS Growth | -21.93% | 0% | 8.59% | -5.02% | 98.04% | 219.06% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Pharmaceuticals and Medicinal Chemical Products Pharmaceuticals and Medicinal Chemical Products Growth | 2,737 | 2,747 | 2,486 | 2,246 | 1,997 | 1,737 |
Elimination of Inter-segment Elimination of Inter-segment Growth | -1,092 | -1,080 | -928.65 | -840.29 | -758.29 | -649.32 |
Total Total Growth | 1,645 | 1,667 | 1,557 | 1,406 | 1,238 | 1,087 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 87.02 | 123.86 | 729.57 | 975.49 | 37.87 | 22.2 |
Total Debt Total Debt Growth | 253.05 | 223.3 | 161.54 | 334.29 | 544.07 | 570.91 |
Net Cash (Debt) Net Cash Growth | -166.03 | -99.44 | 568.03 | 641.2 | -506.19 | -548.71 |
Net Cash Growth | - | - | -11.41% | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.28 | -0.17 | 0.96 | 1.18 | -1.13 | -1.51 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 139.3 | 136.91 | 282.05 | 125.97 | 135.26 | 131.86 |
Capital Expenditures CapEx Growth | -590.09 | -676.51 | -243.38 | -55.72 | -13.69 | -20.96 |
Free Cash Flow Free Cash Flow Growth | -450.79 | -539.6 | 38.67 | 70.26 | 121.57 | 110.9 |
Free Cash Flow Growth | - | - | -44.96% | -42.21% | 9.62% | 962.94% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 58.20% | 58.88% | 56.63% | 56.60% | 56.72% | 52.09% |
Operating Margin | 11.85% | 13.63% | 14.60% | 14.13% | 13.92% | 8.12% |
Pretax Margin | 11.38% | 13.20% | 13.82% | 12.31% | 11.64% | 5.53% |
Profit Margin | 8.88% | 10.31% | 10.85% | 10.26% | 10.12% | 4.71% |
FCF Margin | -27.25% | -32.15% | 2.45% | 4.96% | 9.79% | 10.12% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Period Ending | Jul '26 Jul 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.250 | 0.250 | 0.150 | 0.100 |
Dividend Per Share Growth | 93.33% | 66.67% | 50.00% | - |
Dividend Yield | 6.19% | 6.40% | 3.57% | 2.45% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 16.40 | 13.87 | 16.18 | 18.98 | - | - |
P/FCF Ratio | - | - | 71.69 | 39.28 | - | - |
PS Ratio | 1.47 | 1.43 | 1.76 | 1.95 | - | - |